Cancer Investigation, Volume 19, Issue 5 (2001)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Cancer Investigation, Volume 19, Issue 5 (2001)

See all volumes and issues
Vol 42, 2024 Vol 41, 2023 Vol 40, 2022 Vol 39, 2021 Vol 38, 2020 Vol 37, 2019 Vol 36, 2018 Vol 35, 2017 Vol 34, 2016 Vol 33, 2015 Vol 32, 2014 Vol 31, 2013 Vol 30, 2012 Vol 29, 2011 Vol 28, 2010 Vol 27, 2009 Vol 28, 2010 Vol 27, 2009 Vol 26, 2008 Vol 25, 2007 Vol 24, 2006 Vol 23, 2005 Vol 22, 2004 Vol 21, 2003 Vol 20, 2002 Volume 19, 2001 Vol 18, 2000 Vol 17, 1999 Vol 16, 1998 Vol 15, 1997 Vol 14, 1996 Vol 13, 1995 Vol 12, 1994 Vol 11, 1993 Vol 10, 1992 Vol 9, 1991 Vol 8, 1990 Vol 7, 1989 Vol 6, 1988 Vol 5, 1987 Vol 4, 1986 Vol 3, 1985 Vol 2, 1984 Vol 1, 1983
Download citations Download PDFs Download issue

Original

Article
Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Etoposide (CHOPE) for Advanced-Stage Hodgkin's Disease: CALGB 8856
Eric P. Lester M.D., Gina R. Petroni Ph.D., Maurice Barcos M.D., Jeffrey L. Johnson Ph.D., Fred E. Millard M.D., M. Robert Cooper M.D., George A. Omura M.D., Emil Frei III, M.D. & Bruce A. Peterson M.D.
Pages: 447-458
Published online: 31 May 2001
AbstractforCyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Etoposide (CHOPE) for Advanced-Stage Hodgkin's Disease: CALGB 8856 | Full Text | References | PDF (152.2 KB)
  • 61 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Phase I–II Vinorelbine (Navelbine®) by Continuous Infusion in Patients with Metastatic Breast Cancer: Cumulative Toxicities Limit Dose Escalation
Nuhad K. Ibrahim M.D., Vicente Valero M.D., Zia Rahman M.D., Richard L. Theriault D.O., Ronald S. Walters M.D., Aman U. Buzdar M.D., Daniel J. Booser M.D., Frankie A. Holmes M.D., James L. Murray III, M.D., Jie Willey R.N., M.S.N., Robert Bast M.D. & Gabriel N. Hortobagyi M.D.
Pages: 459-466
Published online: 31 May 2001
AbstractforPhase I–II Vinorelbine (Navelbine®) by Continuous Infusion in Patients with Metastatic Breast Cancer: Cumulative Toxicities Limit Dose Escalation | Full Text | References | PDF (107.8 KB)
  • 38 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
A Phase I–II Trial of Topotecan and Gemcitabine in Patients with Previously Treated, Advanced Non-small Cell Lung Cancer (LOA-3)
David A. Rinaldi M.D., D. Rinaldi M.D., N. Lormand C.C.R.P., J. Brierre M.D., J. Cole M.D., B. Barnes M.D., F. Fontenot P.A.-C., E. Buller P.A.-C. & J. Rainey M.D.
Pages: 467-474
Published online: 31 May 2001
AbstractforA Phase I–II Trial of Topotecan and Gemcitabine in Patients with Previously Treated, Advanced Non-small Cell Lung Cancer (LOA-3) | Full Text | References | PDF (108.4 KB)
  • 19 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Cell Density-Dependent Proliferative Effects of Transforming Growth Factor (TGF)-β1, β2, and β3 in Human Chondrosarcoma Cells HCS-2/8 Are Associated with Changes in the Expression of TGF-β Receptor Type I
Karim Boumèdiene Ph.D., Masaharu Takigawa D.D.S., Ph.D. & Jean-Pierre Pujol
Pages: 475-486
Published online: 31 May 2001
AbstractforCell Density-Dependent Proliferative Effects of Transforming Growth Factor (TGF)-β1, β2, and β3 in Human Chondrosarcoma Cells HCS-2/8 Are Associated with Changes in the Expression of TGF-β Receptor Type I | Full Text | References | PDF (240.3 KB)
  • 40 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Human Leukocyte Antigens (HLA)-Cw as Prognostic Indicators in Autologous Transplantation for Lymphoma
Donna Skerrett M.D., Oksana Rosina C.H.S., Carol Bodian Dr.P.H., Luis Isola M.D., Oksana Gudzowaty C.H.S., Eileen Scigliano M.D. & Steven Fruchtman M.D.
Pages: 487-494
Published online: 31 May 2001
AbstractforHuman Leukocyte Antigens (HLA)-Cw as Prognostic Indicators in Autologous Transplantation for Lymphoma | Full Text | References | PDF (110.5 KB)
  • 31 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Current Status of Ribozymes as Gene Therapy Agents for Cancer
Louise Wright & Phil Kearney Ph.D., M.B.A.
Pages: 495-509
Published online: 31 May 2001
First Page PreviewforCurrent Status of Ribozymes as Gene Therapy Agents for Cancer | Full Text | References | PDF (173 KB)
  • 29 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Magnetic Resonance Imaging and Spectroscopic Imaging of Prostate Cancer
Mark G. Swanson Ph.D, Daniel B. Vigneron Ph.D, Tuan-Khanh C. Tran Ph.D & John Kurhanewicz Ph.D
Pages: 510-523
Published online: 31 May 2001
First Page PreviewforMagnetic Resonance Imaging and Spectroscopic Imaging of Prostate Cancer | Full Text | References | PDF (427.5 KB)
  • 18 Views
  • 21 CrossRef citations
  • 0Altmetric
Article
Understanding the Interaction Between Environmental Exposures and Molecular Events in Colorectal Carcinogenesis
Naoko Ishibe & Andrew N. Freedman Sc.D
Pages: 524-539
Published online: 31 May 2001
First Page PreviewforUnderstanding the Interaction Between Environmental Exposures and Molecular Events in Colorectal Carcinogenesis | Full Text | References | PDF (175.4 KB)
  • 51 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Selenium in Cancer Prevention: Clinical Issues and Implications
Peter C. Raich M.D., Junxuan Lü Ph.D., Henry J. Thompson Ph.D. & Gerald F. Combs Jr., Ph.D.
Pages: 540-553
Published online: 31 May 2001
First Page PreviewforSelenium in Cancer Prevention: Clinical Issues and Implications | Full Text | References | PDF (167.3 KB)
  • 43 Views
  • 36 CrossRef citations
  • 0Altmetric
Article
The HER-2/neu Oncogene in Tumors of the Gastrointestinal Tract
Jeffrey S. Ross M.D. & Barbara j. McKenna M.D.
Pages: 554-568
Published online: 31 May 2001
AbstractforThe HER-2/neu Oncogene in Tumors of the Gastrointestinal Tract | Full Text | References | PDF (219.8 KB)
  • 279 Views
  • 190 CrossRef citations
  • 0Altmetric

Explore articles